Skip to main content
. 2020 Aug 4;318:113968. doi: 10.1016/j.molliq.2020.113968

Table 1.

Summary of the approved antiviral drugs.

# Cpd. Structure/IUPAC name Biological activity
1 Emodin Image 1 Inhibitor of SARS-CoV entry [7]
2 Chloroquine Image 2 Treatment of SARS-CoV-2 [45]
3 hydroxychloroquine Image 3 Treatment of SARS-CoV-2 [45]
4 Remdesivir Image 4 Antiviral drug [46]
5 Aminoquinoline Image 5 Used in malaria treatment [9]
6 Azithromycin Image 6 Broad spectrum antibiotic [12]
7 ethyl (3S)-1-(2a,8a-di(furan-2-yl)-2-oxo-1,2,2a,8a-tetrahydroazeto[2,3-b]quinoxalin-6-yl)piperidine-3-carboxylate Image 7 Cyclophilin D (CypD) inhibitors [47]
8 2,3-di(furan-2-yl)-6-ethoxycarbonylamino quinoxaline Image 8
9 2,3-di(furan-2-yl)-6-((R)-3-ethoxycarbonyl-piperidino) carbonylamino quinoxaline Image 9
10 Cyclosporine A Image 10 In vitro effective against HIV, HCV and HBV replication [48,49]
11 Lopinavir Image 11 (HIV protease inhibitors) [4]
12 Ritonavir Image 12
13 Favipiravir Image 13 SARS-CoV-2 antiviral agent [4]
14 Ribavirin Image 14 HCV antiviral [37]
15 Tideglusib Image 15 Antiviral agent [10]
16 Disulfiram Image 16 FDA-approved drugs [10]
17 Carmofur Image 17
18 Ebselen Image 18 Currently in clinical trials [10]
19 Cinanserin Image 19 Antiviral drug [10]